LVGN7409
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LVGN7409, covering 2024-10-31 to 2025-12-26. Get the full timeline:
Most recent: Clinical Trial Update: Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors [Phase 1]